The latest report by IMARC Group, titled “Clinical Laboratory Services Market Report by Test Type (Human and Tumor Genetics, Clinical Chemistry, Medical Microbiology and Cytology, and Others), Service Provider (Hospital-Based Laboratories, Stand-Alone Laboratories, Clinic-Based Laboratories), Application (Bioanalytical and Lab Chemistry Services, Toxicology Testing Services, Cell and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services, Drug Discovery and Development Related Services, and Others), and Region 2025-2033,” finds that the global clinical laboratory services market size reached USD 256.9 Billion in 2024. Clinical laboratory services are an essential part of the healthcare industry as they are used for the assessment, diagnosis, treatment, prevention and management of patients. They assist in the biological, microbiological, serological, chemical, immune-hematological, biophysical, cytological, pathological, and hematological examination of materials obtained from the human body. They also determine, measure and describe the presence or absence of various substances or organisms in the body. Besides this, clinical laboratories offer data and resources through diagnostic and test results ranging from blood tests to genetic analysis. In recent years, various medical organizations and healthcare institutions have been using software programs and computers to improve accessibility to report results and billing information.
Global Clinical Laboratory Services Market Trends:
The market is primarily driven by the growing instances of chronic diseases such as cancer and diabetes. Clinical laboratory services maintain reliable and correct test results that enable doctors to form relevant clinical and diagnostic decisions across the healthcare system. This is also increasing the demand for early and accurate diagnosis of diseases, thereby fueling the growth of the market. Besides this, the introduction of more accurate and advanced products, such as companion diagnostics, biochips and microarrays, is escalating the demand for clinical laboratory services. In addition, the rising healthcare expenditure and inflating disposable incomes of individuals are also propelling the market growth. Furthermore, advancements in clinical diagnostics, the rising adoption of digital pathology platforms, and the increasing preference for comprehensive health checkups offered by clinical laboratories are expected to create opportunities for the market in the upcoming years. Looking forward, the market value is projected to reach USD 391.8 Billion by 2033, expanding at a CAGR of 4.8% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Test Type, Service Provider, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG) and Thermo Fisher Scientific Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800